TC2N and lung cancer: To evaluate the clinical implication of Tac2-N in different clinical stages, the tissue microarray contains 272 lung cancer lung cancer specimens were probed by IHC and then divided into two groups: low Tac2-N expression (scores< 8) and high Tac2-N (scores ≥8) (Fig. 1a).